Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Defendant: Teva Pharmaceuticals USA Inc.
Case Number: 1:2014cv00874
Filed: July 3, 2014
Court: US District Court for the District of Delaware
Office: Wilmington Office
County: XX US, Outside State
Presiding Judge: Unassigned Judge
Nature of Suit: Patent
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None

Available Case Documents

The following documents for this case are available for you to view or download:

Date Filed Document Text
November 16, 2016 Opinion or Order Filing 204 OPINION. Signed by Judge Sue L. Robinson on 11/16/2016. (nmfn)
September 3, 2015 Opinion or Order Filing 133 MEMORANDUM ORDER re: claim construction. Signed by Judge Sue L. Robinson on 9/3/2015. (fms)
August 5, 2015 Opinion or Order Filing 114 MEMORANDUM ORDER. On or before August 10, 2015, Merck shall produce to the court, for in camera review, Dr. Cockroft's engagement letter with Merck. Signed by Judge Sue L. Robinson on 8/5/2015. Associated Cases: 1:14-cv-00874-SLR-SRF, 1:15-cv-00250-SLR-SRF(nmfn)
July 22, 2015 Opinion or Order Filing 106 ORDER ADOPTING 88 REPORT AND RECOMMENDATIONS granting 8 Motion to Dismiss, denying as moot 8 Motion for Judgment on the Pleadings; denying 12 Motion to Transfer Case. IT IS FURTHER ORDERED that plaintiff may file an amended complaint on or before August 24, 2015. Signed by Judge Sue L. Robinson on 7/22/2015. (nmfn)
July 1, 2015 Opinion or Order Filing 88 REPORT AND RECOMMENDATIONS- DENYING 12 MOTION to Transfer Case to District of New Jersey, GRANTING 8 MOTION to Dismiss with leave to amend Count II of the complaint, and DENYING Teva's motion for judgment on the pleadings as moot. Ple ase note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/20/2015. Signed by Judge Sherry R. Fallon on 7/1/2015. (lih)
Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme Corp.
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?